Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial

Preventive Medicine

Volumn 66, Issue , 2014, Pages 123-130

  Murphy, Caitlin C ^a   Vernon, Sally W ^a   Haddock, Nicole M ^a   Anderson, Melissa L ^b   Chubak, Jessica ^b   Green, Beverly B ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Behavioral intervention research; Cancer screening; Colorectal cancer; Longitudinal study

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SIGMOIDOSCOPY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MIDDLE AGED; PSYCHOLOGY; SELF CONCEPT; STATISTICAL MODEL; UTILIZATION;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SELF EFFICACY;

EID: 84903884348     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.06.013     Document Type: Article

References (52)

1. Bastani R., Maxwell A.E., Bradford C. Cross-section versus prospective predictors of screening mammography. Cancer Epidemiol. Biomarkers Prev. 1996, 5(10):845-848.
2. Breslau N., Reeb K.G. Continuity of care in a university-based practice. J. Med. Educ. 1975, 50(10):965-969.
3. Centers for Disease Control, Prevention (CDC) Cancer screening-United States, 2010. MMWR Morb. Mortal. Wkly Rep. 2012, 61(3):41-45.
4. Church T.R., Yeazel M.W., Jones R.M., Kochevar L.K., Watt G.D., Mongin S.J., et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J. Natl. Cancer Inst. 2004, 96(10):770-780.
5. Coronado G.D., Golovaty I., Longton G., Levy L., Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer 2011, 117(8):1745-1754.
6. Daskalakis C., Vernon S.W., Sifri R., Dicarlo M., Cocroft J., Andrel Sendecki J., et al. The effects of test preference, test access, and navigation on colorectal cancer screening. Cancer Epidemiol. Biomarkers Prev. 2014, (Epub ahead of print 2014 May 9). 10.1158/1055-9965.EPI-13-1176.
7. DeVellis B.M., Blalock S.J., Sandler R.S. Predicting participation in cancer screening: the role of perceived behavioral control. J. Appl. Soc. Psychol. 1990, 20:639-660.
8. Duncan A., Turnbull D., Wilson C., Osborne J.M., Cole S.R., Flight I., et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health 2014, 14:238.
9. Fenton J.J., Elmore J.G., Buist D.S., Reid R.J., Tancredi D.J., Baldwin L.M. Longitudinal adherence with fecal occult blood test screening in community practice. Ann. Fam. Med. 2010, 8(5):397-401.
10. Gellad Z.F., Stechuchak K.M., Fisher D.A., et al. Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am. J. Gastroenterol. 2011, 106(6):1125-1134.
11. Glenn B., Bastani R., Reuben D. How important are psychosocial predictors of mammography receipt among older women when immediate access is provided via on-site service?. Am. J. Health Promot. 2006, 20(4):237-246.
12. Green B.B., Wang C.Y., Horner K., Catz S., Meenan R.T., Vernon S.W., et al. Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp. Clin. Trials 2010, 31(6):589-603.
13. Green B.B., Bogart A., Chubak J., Vernon S.W., Morales L.S., Meenan R.T., et al. Nonparticipation in a population-based trial to increase colorectal cancer screening. Am. J. Prev. Med. 2012, 42(4):390-397.
14. Green B.B., Wang C.Y., Anderson M.L., Chubak J., Meenan R.T., Vernon S.W., et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann. Intern. Med. 2013, 158(5 Pt 1):301-311.
15. Gupta S., Halm E.A., Rockey D.C., Hammons M., Koch M., Carter E., et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern. Med. 2013, 173(18):1725-1732.
16. Hardcastle J.D., Armitage N.C., Chamberlain J., Amar S.S., James P.D., Balfour T.W. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer 1986, 58(2):397-403.
17. Hardcastle J.D., Thomas W.M., Chamberlain J., Pye G., Sheffiled J., James P.D., et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989, 1(8648):1160-1164.
18. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348(9040):1472-1477.
19. Hoogewerf P.E., Hislop T.G., Morrison B.J., Burns S.D., Sizto R. Health belief and compliance with screening for fecal occult blood. Soc. Sci. Med. 1990, 30:721-726.
20. Hosmer D.W., Lemeshow S., Sturdivant R.X. Applied Logistic Regression 2013, Wiley, Hoboken, NJ. 3rd ed.
21. Inadomi J.M., Vijan S., Janz N.K., Fagerlin A., Thomas J.P., Lin Y.V., et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 2012, 172(7):575-582.
22. Kremers S.P., Mesters I., Pladdet I.E., van den Borne B., Stockbrugger R.W. Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2000, 9(10):1127-1130.
23. Liss D.T., Petit-Homme A., Feinglass J., Buchanan D.R., Baker D.W. Adherence to repeat fecal occult blood testing in an urban community health center network. J. Community Health 2013, 38(5):829-833.
24. Mandel J.S., Church T.R., Ederer F., Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl. Cancer Inst. 1999, 91(5):434-437.
25. Manne S.L., Coups E.J., Markowitz A., Meropol N.J., Haller D., Jacobsen P.B., et al. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann. Behav. Med. 2009, 37(2):207-217.
26. McQueen A., Vernon S.W., Myers R.E., Watts B.G., Lee E.S., Tilley B.C. Correlates and predictors of colorectal cancer screening among male automootive workers. Cancer Epidemiol. Biomarkers Prev. 2007, 16(3):500-509.
27. McQueen A., Tiro J.A., Vernon S.W. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol. Biomarkers Prev. 2008, 17(9):2231-2237.
28. McQueen A., Vernon S.W., Rothman A.J., Norman G.J., Myers R.E., Tilley B.C. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann. Behav. Med. 2010, 40(2):205-217.
29. Menon U., Champion V.L., Larkin G.N., Zollinger T.W., Gerde P.M., Vernon S.W. Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program. J. Occup. Environ. Med. 2003, 45(8):891-898.
30. Murphy C.C., McQueen A., Bartholomew L.K., Del Junco D.J., Coan S.P., Vernon S.W. Factorial validity and invariance of four psychosocial constructs of colorectal cancer screening: does screening experience matter?. Cancer Epidemiol. Biomarkers Prev. 2013, 22(22):2295-2302.
31. Murphy C.C., Vernon S.W., Diamond P.M., Tiro J.A. Competitive testing of health behavior theories: how do benefits, barriers, subjective norm, and intention influence mammography behavior?. Ann. Behav. Med. 2014, 47(1):120-129.
32. Myers R.E., Balshem A.M., Wolf T.A., Ross E.A., Millner L. Adherence to continuous screening for colorectal neoplasia. Med. Care 1993, 31(6):508-519.
33. Myers R.E., Ross E., Jepson C., Wolf T., Balshem A., Millner L., et al. Modeling adherence to colorectal cancer screening. Prev. Med. 1994, 23(2):142-151.
34. Myers R.E., Sifri R., Hyslop T., Rosenthal M., Vernon S.W., Cocroft J., et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer 2007, 110(9):2083-2091.
35. Myers R.E., Bittner-Fagan H., Daskalakis C., Sifri R., Vernon S.W., Cocroft J., et al. A randomized controlled trail of a tailored navigation and standard intervention in colorectal cancer screening. Cancer Epidemiol. Biomarkers Prev. 2013, 22(1):109-117.
36. Oluyemi A.O., Welch A.R., Yoo L.J., Lehman E.B., McGarrity T.J., Chuang C.H. Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind. Cancer 2014, (Epub ahead of print 2014 Apr 15). 10.1002/cncr.28707.
37. Rakowski W., Clark M.A., Ehrich B. Smoking and cancer screening for women ages 42-75: associations in the 1990-1994 National Health Interview Surveys. Prev. Med. 1999, 29(6 Pt 1):487-495.
38. Rawl S., Champion V., Menon U., Loehrer P.J., Vance G.H., Skinner C.S. Validation of scales to measure benefits of and barriers to colorectal cancer screening. J. Psychosoc. Oncol. 2001, 19(3/4):47-63.
39. Ritvo P., Myers R., Del Giudice M.L., Pazsat L., Campbell P.T., Howlett R.I., et al. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada-a replication study. Cancer Epidemiol. Biomarkers Prev. 2008, 17(11):3279-3283.
40. Sabatino S.A., Lawrence B., Elder R., Mercer S.L., Wilson K.M., DeVinney B., et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am. J. Prev. Med. 2012, 43(1):97-118.
41. Sequist T.D., Zaslavsky A.M., Marshal R., Fletcher R.H., Ayanian J.Z. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch. Intern. Med. 2009, 169(4):364-371.
42. Siegel R., Naishadham D., Jemal A. Cancer Statistics, 2013. CA Cancer J. Clin. 2013, 63(1):11-30.
43. Sifri R., Rosenthal M., Hyslop T., Andrel J., Wender R., Vernon S.W., et al. Factors associated with colorectal cancer screening decision stage. Prev. Med. 2010, 51(3-4):329-331.
44. Starfield B., Weiner J., Mumford L., Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv. Res. 1991, 26(1):53-74.
45. Taplin S.H., Barlow W.E., Ludman E., MacLehos R., Meyer D.M., Seger D., et al. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J. Natl. Cancer Inst. 2000, 92(3):233-242.
46. Tilley B.C., Vernon S.W., Myers R., Glanz K., Lu M., Hirst K., et al. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev. Med. 1999, 28(3):276-283.
47. Tiro J.A., Vernon S.W., Hyslop T., Myers R.E. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol. Biomarkers Prev. 2005, 14(12):2855-2861.
48. Vernon S.W., McQueen A. Colorectal Cancer Screening. Psycho-Oncology 2010, 71-83. Oxford University Press, New York. 2nd edition. J.C. Holland, W.S. Breitbart, P.B. Jacobsen, M.S. Lederberg, M.J. Loscalzo, R. McCorkle (Eds.).
49. Vernon S.W., Bartholomew L.K., McQueen A., Bettencourt J.L., Greisinger A., Coan S.P., et al. A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann. Behav. Med. 2011, 41(3):284-299.
50. Walsh J.M., Salazar R., Nguyen T.T., Kaplan C., Nguyen L.K., Hwang J., et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am. J. Prev. Med. 2010, 39(1):1-14.
51. Weiner J.P., Starfield B.H., Steinwachs D.M., Mumford L.M. Development and application of a population-oriented measure of ambulatory care case-mix. Med. Care 1991, 29(5):452-472.
52. Zauber A.G., Lansdorp-Bogelaar I., Knudsen A.B., Wilschut J., van Ballegooijen M., Juntz K.M. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2008, 149(9):659-669.